Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.95%	22.16	$
VOD	-1.27%	14.12	$
RIO	-0.76%	99.33	$
BCE	-2.76%	22.655	$
BCC	-2.94%	72.53	$
RELX	-1.1%	30.84	$
NGG	1.88%	80.96	$
GSK	0.14%	50.74	$
RBGPF	0.59%	61.5	$
JRI	0.04%	12.675	$
CMSD	-0.86%	22.1	$
BTI	0%	58.91	$
RYCEF	1.03%	18.45	$
AZN	0.81%	176.35	$
BP	1.67%	39.765	$

Featured

Qatar gas plant blast kills 13, injures dozens

A huge blast at a Qatar gas hub killed 13 people and injured 66 others, the state's energy minister said on Monday, providing an update on one of the deadliest ever accidents at a Gulf energy facility.

Rare Philippine school shooting kills three teens, wounds seven

Two students opened fire Monday inside a school in the central Philippines, a rare campus shooting that killed three teens and wounded seven others, police said.

Last news

Cosmoprof North America Miami Returns for Its Third Edition, January 27-29, 2026: Staying Ahead in Beauty, Innovation, and Industry Insights

More than 800 brands and suppliers unite in Miami to showcase the future of beauty across skin care, makeup, fragrance, hair, nails, and the entire supply chain.

HPB and Coperion Partner on Next-Generation Slurry Production

New to The Street will be covering across all media.

Fast Finance Pay Corp Reports Third Quarter 2025 Financial Results

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Fast Finance Pay Corp. (OTCID:FFPP) today reported financial results for the three and nine months ended September 30, 2025, and provides a business update.

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting

Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to surviveGroundbreaking PS reduction of up to 37% is unprecedented; No approved treatments exist for MVID

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society (NRS) Seal of Acceptance.

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

NEW YORK CITY, NY / ACCESS Newswire / November 13, 2025 / Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel therapeutics for stress-related neuropsychiatric and neurodegenerative disorders, today announced the successful completion of enrollment and dosing in its Multiple Ascending Dose (MAD) Phase 1 study evaluating its lead compound, known as PT00114. The study, conducted in healthy volunteers, was designed to assess the safety and tolerability profile of PT00114 following multiple doses over time. With all healthy volunteers now dosed, the company has achieved a milestone in the clinical development of its proprietary peptide-based therapeutic.

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM

Pivotree Announces Third Quarter 2025 Results

Four Consecutive Quarters of Strong Gross Margins and Operational Discipline Drive $7.2M in Adjusted EBITDA and $3.6M in Net Income Over Trailing-Twelve Months.

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise

KUALA LUMPUR, MY / ACCESS Newswire / November 13, 2025 / BMS Holdings Berhad ("BMS Holdings" or the "Company"), a deep-rooted Malaysian retailer and distributor specialising in tiles, stone surfaces, bathware and kitchenware, successfully launched its prospectus today in conjunction with its upcoming Initial Public Offering ("IPO") and listing on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities").

US jury: Boeing owes $28 mn to family of Ethiopian Airlines crash victim

A US jury in the first civil trial over a fatal Boeing 737 MAX crash determined Wednesday that the aircraft manufacturing giant owes $28.45 million to the family of a newly-wed Indian victim.

Back on track: Belgian-Dutch firm rescues Berlin to Paris sleeper train

Railway fans devastated by the scrapping of a much-heralded Berlin to Paris night train can breathe again after a Belgian-Dutch cooperative stepped in Wednesday to keep the service going.

Algeria pardons writer Boualem Sansal

Algeria has pardoned French-Algerian writer Boualem Sansal after a request from Germany, to where he will be transferred for medical treatment after a year in detention, it was announced Wednesday.

Pope Leo reels off four favourite films

Pope Leo XIV has revealed his four favourite films ahead of a special audience with Hollywood celebrities and Oscar-winning directors at the Vatican.

Pakistan tightens Islamabad security after suicide blast

Residents in the Pakistani capital Islamabad were facing tightened security checks on Wednesday in the wake of a suicide bombing that left top officials vowing to halt the rise in deadly attacks.

Corruption scandal, court battles pose test for Zelensky

A major corruption scandal and mounting accusations that the Ukrainian presidency is using the judiciary to intimidate and silence critics has rocked Kyiv, presenting a significant test for Volodymyr Zelensky almost four years into the Russian invasion.

DR Congo ex-rebel leader Lumbala's war crimes trial opens in Paris

Former Congolese rebel leader Roger Lumbala goes on trial in Paris Wednesday over atrocities committed in the Democratic Republic of Congo's bloody eastern conflict more than two decades ago.

Cambodia's Prince Group denies link to scams after asset seizures

A Cambodian conglomerate whose founder has had more than $15 billion of allegedly ill-gotten assets seized said it "categorically rejects" claims he amassed his fortune running an internet scam empire.

Ousted Gabon leader's wife and son sentenced to 20 years for graft

A Gabon court on Wednesday sentenced the former first lady and son of the oil-rich country's deposed leader Ali Bongo to 20 years in prison following a two-day graft trial.

Bangladesh's liquor industry a surprising success

Syrupy aromas drift across the guarded compound of Bangladesh's only licensed distillery, a state-owned producer posting record profits in the Muslim-majority nation, where Islamists are staging a political comeback.

Duane Boise and MMJ International Holdings Send Urgent Relief to Jamaica Following Category 5 Hurricane Melissa

YouTube: Duane Boise - EMED JamaicaDuane Boise Leads Hurricane Relief Efforts in Jamaica While Confronting DEA Barriers Blocking Life Saving Cannabis Medicines in the U.S.Duane Boise, who has a long history of service to the Jamaican people through medical and emergency relief initiatives, is organizing and funding a series of shipments of food, medical supplies, and emergency goods to assist communities hardest hit by the hurricane. His coordinated effort-supported by MMJ International Holdings and international partners-aims to reach isolated parishes where infrastructure has been destroyed and local services remain disrupted.

Electronic Caregiver's Addison Care(R): As OpenAI Considers Consumer Health Devices, the Future Is Already Here

LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 12, 2025 / Following reports that OpenAI is exploring the launch of consumer health devices and monitoring tools, Electronic Caregiver, Inc. ("ECG"), developer of the Addison Care® virtual caregiver and TeleCare ecosystem, confirms that the future these AI giants are racing toward has already been built and is in market today.

MD&M West Returns with Focus on Sustainability, Healthcare Innovation

ANAHEIM, CA / ACCESS Newswire / November 12, 2025 / Registration is now open for MD&M West, the most comprehensive manufacturing trade show in North America, taking place February 3-5, 2026, at the Anaheim Convention Center in Anaheim.

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company has issued and sold Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants have an exercise price of $1.75 per share, are exercisable after 6 months from date of issuance, and expire 2 years following the issuance date. The Series B Warrants have an exercise price of $2.00 per share, are exercisable after 6 months from date of issuance, and expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025.

Dolphin Announces Record Q3 Revenue of $14.8 Million, up 16.7% YoY

Operating Income Turns Positive $300,000 Even With Almost $600,000 of Non-Cash Amortization ExpensesCEO believes Dolphin is undervalued, purchases approximately 2% of outstanding shares since April 2025

ADM Toronto 2025 Concludes with 26% Attendance Growth, Showcasing Canadian Manufacturing Innovation and Advanced Technologies

Three days of groundbreaking exhibitions, expert insights, and strategic connections drive Canada's manufacturing sector forward.

Federal HEMP Crackdown & Cannabis Court Rulings Confirm MMJ's Pharmaceutical Vision

As Congress and the courts reaffirm federal supremacy in cannabis-hemp regulation, MMJ International Holdings stands with a DEA licensed lab, two accepted FDA Investigational new drug applications, and a completed THC-CBD soft gelatin medicine-proving that true compliance, not state loopholes, defines the future of cannabis medicine.

iTolerance CEO, Anthony Japour, Receives BioFlorida's Research & Developer of the Year Award

MIAMI, FL / ACCESS Newswire / November 12, 2025 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Anthony Japour, Chief Executive Officer and President of iTolerance, received the Research & Developer of the Year Award at the recently held BioFlorida Innovation Conference in Miami, FL.

Dolphin Clients Earn 35 Nominations for the 2026 GRAMMY Awards

Shore Fire Clients Alison Krauss & Union Station, Anoushka Shankar, Arturo O'Farrill & The Afro Latin Jazz Orchestra, Bon Iver, Margo Price, PJ Morton, Samara Joy, Tasha Cobbs Leonard, Tobias Jesso Jr. and 42West Client Andrew Watt All Receive Multiple NominationsAdditional Nods Include Shore Fire Clients Bilal, Bruce Springsteen, Deborah Silver & The Count Basie Orchestra, Grace Potter, Jacob Collier, Joni Mitchell (Rhino Entertainment), Rhiannon Giddens, Samantha Fish, TajMo (Taj Mahal & Keb' Mo'), Terri Lyne Carrington and Trombone Shorty

The Dixie Group Reports Net Loss For The Third Quarter Of 2025

DALTON, GA / ACCESS Newswire / November 12, 2025 / The Dixie Group, Inc. (OTCQB:DXYN) today reported financial results for the quarter ended September 27, 2025.

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

KELOWNA, BC / ACCESS Newswire / November 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update on the Material Transfer Agreement ("MTA") originally entered into on September 4, 2024 with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECHTM technology in a pre-clinical setting.

Arizona Tribune - Boulevard (English)